UAB To Test Potential COVID-19 Vaccine

 1561903774 
1585586365

Back view of Scientist testing Vaccine Coronavirus in Biosafety Cabinet

The University of Alabama at Birmingham

By BirminghamWatch

The University of Alabama at Birmingham and the biopharmaceutical company Altimmune Inc. will test a potential vaccine for COVID-19, the university announced today.

Testing of the vaccine, AdCOVID, which was developed by the company based in Gaithersburg, Maryland, will begin in mice during the second quarter of this year. That phase of testing, designed to show the immune response to the drug in mice, is expected to take one to two months, UAB said in announcing the collaboration.

The vaccine is given in a single dose of intranasal spray, UAB said. If results of the tests in mice warrant, Altimmune could launch a Phase 1 human safety trial during the third quarter of this year.

The announcement by UAB said Altimmune “has significant experience in the development of intranasal vaccine candidates for respiratory pathogens, including a seasonal and pandemic influenza vaccine and a vaccine for inhalation anthrax.”

“We are eager to collaborate with Altimmune on this important project,” said Frances E. Lund, the Charles H. McCauley Professor and Chair for the UAB Department of Microbiology. “The expertise and infrastructure at UAB will be invaluable to the rapid progression of this vaccine into clinical studies.

Lund said six labs at UAB will work on the project.

Vipin K. Garg, president and CEO of Altimmune, cited UAB’s role in research in virology and immunology. He said the company was founded through a technology license from UAB in 1997.

“It is critical that the biotechnology industry and academic institutions work together to prevent the further spread of COVID-19, and UAB is an ideal partner to support us in this effort,”Garg said.

UAB also has extensive experience in conducting clinical studies of vaccines and has participated in studies sponsored by the Vaccine Evaluation and Trial Unit, part of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.

The vaccine being tested “will activate mucosal and cellular immune responses, as well as a strong antibody response in the blood,” the announcement said.

“If the AdCOVID vaccine candidate is as stable as Altimmune’s influenza and anthrax vaccines candidates, that may allow inexpensive and efficient distribution of the millions of doses needed for widespread vaccination of populations,” the statement said.

 

Jefferson County health providers ‘well equipped’ for The World Games

Officials plan to treat as many people as possible at on site medical tents. They say the biggest concern is heat-related illness.

Birmingham City Council passes Woodfin’s budget untouched

Police, public works and youth programs were the biggest winners in the $517 million budget, the largest ever for the city.

Woodfin says people without homes won’t be moved from public spaces for The World Games

World Games officials clarified that anyone will be able to walk through and access public areas around venues like Railroad Park, Linn Park, Protective Stadium and the new City Walk, despite those sites being behind security parameters.

Groups oppose $725 million Alabama bond sale for building prisons

The state is expected to go to the bond market on Tuesday, to provide financing for the construction plan. That money will be added to $135 million in state funds and $400 million in pandemic relief dollars that the state already agreed to put toward the construction project.

“Expect us,” reproductive rights supporters rally across Alabama after federal abortion ruling

Alabamians took to the streets this weekend after elective abortions became a felony in the state on Friday.

More BirminghamWatch Coverage